Curemark Completes Enrollment Of Phase III Autism Trials

Links shared publicly online about this topic.

421
total visits

Curemark Completes Enrollment Of Phase III Autism Trials

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company has completed its targeted enrollment of Phase III clinical tri

View full resource at medicalnewstoday.com

Tags: Neurology, Autism Spectrum Disorder, Autism, Disease and Condition, Drug, disease

Most Recently Shared on March 22, 2011 at 8:05 am By:

MNT Clinical Trials

Curemark Completes Enrollment Of Phase III Autism Trials http://mnt.to/3Sxs #clinicaltrials

1 year ago...

Retweet

Favorite

Also Shared By:

MNT Autism News

Curemark Opens Patient Enrollment For Autism Treatment At Three More Clinical Trial Sites

medicalnewstoday.com — “Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company has begun enrolling patients in Phase III clinical trials for CM” View full resource at medicalnewstoday.com

Most Recently Shared on November 20, 2009 at 1:22 pm By:

MNT Clinical Trials Health News

Curemark Opens Patient Enrollment For Autism Treatment At Three More Clinical Trial Sites: Curemark LLC, a drug.. http://bit.ly/VLv9F

3 years ago...

Retweet

Favorite

Curemark Enrolls First Patients In Phase III Clinical Trials For Autism Treatment

medicalnewstoday.com — “Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that it has enrolled the first patients in Phase III clinical trials for its aut” View full resource at medicalnewstoday.com